@drtimos.bsky.social📊 Investment Insights | Advisory | #Fundraising 🚀
At #LucidQuest we help funds & founders turn intelligence into alpha—fast, evidence-based answers before capital moves.
📩 [email protected] or http://dlvr.it/TVpkS8
#VentureCapital #PrivateEquity #HedgeFunds #DealFlow
@drtimos.bsky.social🚀 #DigitalHealth | #AI | #IoE 🌐
At #LucidQuest, we turn bold ideas into patient-centric, AI-powered solutions for #Pharma, #Biotech & #HealthTech.
Let’s shape the future of care together.
📩 [email protected] or
@drtimos.bsky.social👋 CGT and RNA peers, what is the single 90 day challenge blocking you? Share in 60 seconds: http://dlvr.it/TVpCJt
Then join the Gene, Cell and RNA Therapy Strategy Network: http://dlvr.it/TVpCK7
@drtimos.bsky.socialLucidQuest YouTube > Obesity Strategic Roundup | September 1 - October 4, 2026: From September 1 – October 4, 2026, obesity competition expanded beyond headline weight-loss efficacy toward a broader contest involving tolerability, convenience, portfolio… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.social🚀 Contributed to FirstWord report on AI in personalized medicine: smarter trials, faster discovery 🧬💊. Early AI drugs show 80–90% Ph 1 success! 🌍 Challenges remain, but partnerships & continuous learning will drive the future. #LucidQuest
Read more 👉 http://dlvr.it/TVnxtH
@drtimos.bsky.social🚨 Who’s leading BioPharma (+ Google) CVC in 2025?
🔎 #LucidQuest analyzed 22 CVCs—focus by Tech & Therapy Areas + shifts vs. 2023.
Grab the FREE snapshot ⚡
@drtimos.bsky.socialYour launch may look great on Google, but AI answers can cite others. #LucidScope tracks perception + answer differences across models and personas, with source tracing and risk flags. Start with an AI Answer Audit: http://dlvr.it/TVmTCH #LucidQuest
@drtimos.bsky.socialZero-click is here: AI summaries decide what gets seen. #LucidScope benchmarks how major models describe you vs competitors, spots outdated or hallucinated claims, and recommends content + schema actions. Request an audit: http://dlvr.it/TVmCZy #LucidQuest
@drtimos.bsky.social🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TVlvNd #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII
@drtimos.bsky.social🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TVlYyc #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@drtimos.bsky.socialWhat if strategy felt like live chess?
#LucidWargames runs dynamic sims, pits you vs adaptive AI rivals, adjudicates by KPIs, and maps odds with 100+ Monte Carlo runs.
Prep or power your next session with rigor: http://dlvr.it/TVl7pL
Demo: http://dlvr.it/TVl7pM
#LucidQuest
@drtimos.bsky.socialFrom slides to simulations. #LucidWargames, a multi-agent engine, pressure tests strategy with evolving scenarios, objective scoring, and probability maps from 100+ Monte Carlo runs. Optimize your next workshop: http://dlvr.it/TVl4gW Demo: http://dlvr.it/TVl4gf #LucidQuest
@drtimos.bsky.social🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TVkgfk !
@drtimos.bsky.socialStay ahead in healthcare innovation.
Subscribe to #LucidQuest's Weekly LQ AI Report for #AI breakthroughs, #PrecisionMedicine insights & #DigitalHealth trends.
Get tips & success stories delivered to your inbox. http://dlvr.it/TVkWPL
@drtimos.bsky.socialLucidQuest YouTube > Cardiovascular Strategic Roundup | Aug 27- Sep 30, 2026: The Cardiovascular Strategic Roundup covering 27 August 2026 to 30 September 2026 explores how the market is shifting toward next-generation intervention strategies focused on… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.social🚀 Get the #Oncology buzz from #ASCOGI25!
Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺
Download our full report! http://dlvr.it/TVk8mN
@ASCO
#SocialListening #LucidQuest
@drtimos.bsky.social#LucidQuest helps Pharma/Biotech/HealthTech teams turn market signals into decisions, fast.
Start with #QuickAnswers (rapid primary + secondary CI), scale to deeper projects, conference coverage, #LucidWargames simulations, #LucidScope AI narrative audits, and #NexusBrain insight capture.
@drtimos.bsky.socialLucidQuest YouTube > Neuroscience Strategic Roundup | August 25 - September 29, 2026: The Neuroscience Strategic Roundup covering August 25 - September 29, 2026 explores how treatment differentiation is expanding beyond efficacy alone through new… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.social🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TVjLws | 📧 Talk to experts: [email protected]
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest
@drtimos.bsky.social🚀 Conference coverage to #CGT strategy. #LucidQuest turns congress signals into structured intel: what changed, who it affects, next steps for teams and investors. Previews, recaps, KOLs, CI tracking, decision-ready outputs. 📩 [email protected]